James D Best
Overview
Explore the profile of James D Best including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1929
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Januszewski A, Chen D, Scott R, OConnell R, Aryal N, Sullivan D, et al.
Sci Rep
. 2021 Sep;
11(1):18708.
PMID: 34548531
People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs,...
2.
Dunbar J, Versace V, Janus E, Laatikainen T, Vartiainen E, Absetz P, et al.
Curr Diab Rep
. 2019 Nov;
19(11):130.
PMID: 31748826
No abstract available.
3.
Boyle D, Versace V, Dunbar J, Scheil W, Janus E, Oats J, et al.
PLoS One
. 2018 Aug;
13(8):e0200832.
PMID: 30089149
Objective: Gestational Diabetes Mellitus (GDM) increases the risk of type 2 diabetes. A register can be used to follow-up high risk women for early intervention to prevent progression to type...
4.
Michalczyk A, Janus E, Judge A, Ebeling P, Best J, Ackland M, et al.
Epigenomics
. 2018 Mar;
10(4):419-431.
PMID: 29561170
Aim: To investigate epigenomic changes in pregnancy and early postpartum in women with and without type 2 diabetes. Methods: Dimethylation of histones H3K4, H3K9, H3K27, H3K36 and H3K79 was measured...
5.
Waldman B, Ansquer J, Sullivan D, Jenkins A, McGill N, Buizen L, et al.
Lancet Diabetes Endocrinol
. 2018 Mar;
6(4):310-318.
PMID: 29496472
Background: Gout is a painful disorder and is common in type 2 diabetes. Fenofibrate lowers uric acid and reduces gout attacks in small, short-term studies. Whether fenofibrate produces sustained reductions...
6.
Ong K, OConnell R, Januszewski A, Jenkins A, Xu A, Sullivan D, et al.
Clin Chem
. 2017 Jun;
63(7):1261-1270.
PMID: 28606915
Background: It is not known whether circulating fibroblast growth factor 21 (FGF21) concentrations are associated with glycemic progression in patients with established type 2 diabetes. This study reports this relationship...
7.
Ritte R, Luke J, Nelson C, Brown A, ODea K, Jenkins A, et al.
BMC Nephrol
. 2016 Aug;
17(1):113.
PMID: 27495237
Background: Chronic kidney disease (CKD) and end-stage-kidney disease (ESKD) continue to be under-diagnosed and a major burden for Aboriginal communities in central Australia. The aim of this study was to...
8.
OReilly S, Dunbar J, Versace V, Janus E, Best J, Carter R, et al.
PLoS Med
. 2016 Jul;
13(7):e1002092.
PMID: 27459502
Background: Gestational diabetes mellitus (GDM) is an increasingly prevalent risk factor for type 2 diabetes. We evaluated the effectiveness of a group-based lifestyle modification program in mothers with prior GDM...
9.
Michalczyk A, Dunbar J, Janus E, Best J, Ebeling P, Ackland M, et al.
J Clin Endocrinol Metab
. 2016 Apr;
101(6):2396-404.
PMID: 27045797
Context: Lifestyle factors mediate epigenetic changes that can cause chronic diseases. Although animal and laboratory studies link epigenetic changes to diabetes, epigenetic information in women with gestational diabetes (GDM) and...
10.
Dunbar J, Hernan A, Janus E, Vartiainen E, Laatikainen T, Versace V, et al.
BMJ Open Diabetes Res Care
. 2015 Oct;
3(1):e000131.
PMID: 26464804
Objective: To assess effectiveness and implementability of the public health programme Life! Taking action on diabetes in Australian people at risk of developing type 2 diabetes. Research Design And Methods:...